Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04732819 · ClinicalTrials.gov registry record · NA
Improving COVID-19 Vaccine Uptake in Nursing Homes
A NA study, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 23,768
- Enrollment target
NCT04732819: Completed NA study, sponsored by Brown University.
NCT04732819 is a NA study that has completed, run by Brown University. The registered enrollment target is 23,768 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1594% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04732819, a NA study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23,768 participants
- Enrollment target
Study Summary
SARS-CoV-2 vaccine, now being administered to skilled nursing facility (SNF) residents and staff, has highly variable acceptance between facilities. The investigators need to develop and disseminate effective strategies to increase vaccination immediately. For SNF residents and staff, the investigators will develop and implement a scalable multi-pronged intervention that educates, builds trust and supports the informed consent process aimed to increase SARS-CoV-2 vaccination. The investigators will conduct a cluster randomized trial to compare the effect of electronic messaging and education (i.e., usual care) versus a multi-pronged 'high touch' intervention to reduce vaccine hesitancy in skilled nursing facility staff and residents among a random sample of facilities across four SNF chains. As part of the 'high touch' intervention, the investigators will identify and train local opinion leaders. The investigators will offer these leaders assistance through real-time support for questions and provide consenting specialists. During the second wave of vaccination, the investigators will provide the intervention facilities with positive reinforcement for staff and will identify local champions to garner support and empowerment of staff. Finally, in the intervention facilities, the investigators will provide additional funds to support COVID-19 testing, in order that facilities have access to enough testing kits for patient or staff who develops symptoms following vaccination. This trial will be randomized within four SNF chains in order to evaluate the effect of a multi-pronged strategy to improve SARS-CoV-2 vaccine acceptance among direct care staff and long-stay nursing home residents. In four chains, eligible facilities will undergo randomization between usual care versus adding the 'high touch' intervention, implemented in two waves. Randomization and roll out of the intervention will occur at the facility level. The investigators hypothesize that: (1) the inter
Primary Outcome
A binary measure (Yes or No) indicating whether a long stay nursing home resident received any dose of a SARS-CoV-2 vaccine, identified by the electronic medical records (EMR) within the study period.
Interventions
- BEHAVIORAL High touch multi-pronged behavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,768 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2021-04-16 |
| Phase | NA |
What the finished NCT04732819 record still lists
NCT04732819 is an interventional study that assigns participants to a tested intervention. Its 23,768 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1594% higher).
The record links to 0 conditions, and to 1 intervention - of which High touch multi-pronged behavioral intervention is the first listed.
NCT04732819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04732819 about?
NCT04732819 is a clinical study titled "Improving COVID-19 Vaccine Uptake in Nursing Homes". SARS-CoV-2 vaccine, now being administered to skilled nursing facility (SNF) residents and staff, has highly variable acceptance between facilities. The investigators need to develop and disseminate effective strategies to increase vaccination immediately. For SNF residents and staff, the investigat...
What is the current status of trial NCT04732819?
This trial is currently completed. It is a NA study. The enrollment target is 23,768 participants. The study started on 2020-12-21. Estimated completion is 2021-04-16.
What interventions are being tested in trial NCT04732819?
The interventions under investigation include: High touch multi-pronged behavioral intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04732819?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04732819's enrollment target sits among peer trials
23,768 10th of 2000 higher than 1,991 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06995898 · 24,000 participants · NA
The Vanguard Study: Testing a New Way to Screen for Cancer
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
- NCT06589310 · 25,000 participants
Falcon Real World Evidence Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI